Kenneth heston Bardales
๐Ÿ“ฃ ๐— ๐—ผ๐—ป๐˜๐—ต๐—น๐˜† ๐—ฃ๐—ผ๐—ฟ๐˜๐—ณ๐—ผ๐—น๐—ถ๐—ผ ๐—จ๐—ฝ๐—ฑ๐—ฎ๐˜๐—ฒ โ€“ ๐——๐—ฒ๐—ฐ๐—ฒ๐—บ๐—ฏ๐—ฒ๐—ฟ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ ๐ŸŒฑ โ€ข ๐— ๐—ผ๐—ป๐˜๐—ต๐—น๐˜† ๐—ฅ๐—ฒ๐˜๐˜‚๐—ฟ๐—ป: +1.68% โ€ข ๐—ฌ๐—ง๐——: +26.05% ๐—ง๐—ผ๐—ฝ ๐—–๐—ผ๐—ป๐˜๐—ฟ๐—ถ๐—ฏ๐˜‚๐˜๐—ผ๐—ฟ๐˜€ (๐— ๐—ง๐——): โ€ข iShares Silver Trust (SLV): +24.08% โ€ข Moderna Inc (MRNA): +23.03% โ€ข Micron Technology Inc (MU): +19.74% ๐—•๐—ถ๐—ด๐—ด๐—ฒ๐˜€๐˜ ๐——๐—ฒ๐˜๐—ฟ๐—ฎ๐—ฐ๐˜๐—ผ๐—ฟ๐˜€ (๐— ๐—ง๐——): โ€ข Flare (FLR): -21.05% โ€ข Netflix Inc (NFLX): -13.87% โ€ข Snowflake Inc (SNOW): -12.43% ๐—–๐—ผ๐—บ๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐—ฟ๐˜† December closed with a solid monthly advance, reinforcing a strong year to date trajectory driven by disciplined execution and diversified exposure. Strength across selected growth and thematic positions supported performance, with silver related exposure and biotechnology standing out due to improving sentiment and favorable positioning. Semiconductor exposure also added value as relative strength offset weakness in isolated areas. On the downside, pressure in selected technology names and digital assets created temporary headwinds, though overall portfolio volatility remained contained. Risk management, position sizing, and liquidity discipline continued to play a central role throughout the month. The portfolio remains focused on quality businesses, durable earnings profiles, and selective catalysts rather than broad market beta. Looking ahead, attention remains on macro signals, rate expectations, and company level execution as we seek to protect capital while compounding returns consistently over the long term. ๐—•๐—ฒ๐—ป๐—ฐ๐—ต๐—บ๐—ฎ๐—ฟ๐—ธ ๐—–๐—ผ๐—ป๐˜๐—ฒ๐˜…๐˜ โ€” VOO (S&P 500): +16.85% YTD | QQQ (NASDAQ 100): +20.69% YTD ๐Ÿ“„ ๐—™๐—ฎ๐—ฐ๐˜ ๐—ฆ๐—ต๐—ฒ๐—ฒ๐˜: bullaware.com/etoro/khbardales ๐Ÿ’ก Portfolio designed for long term growth with a multi year horizon. Thank you for your continued trust and support.
null
.